Thursday November 26 2009 | Biotechnology feed | All feeds
|
|
Millenia Hope
Download detailed PDF Members: Millenia Hope is a biopharmaceutical company focused on comprehensive solutions to the problem of world disease. The company’s objective is to fight disease through a portfolio of health products, developed by Millenia Hope and its team of clinical associates based around the world. Millenia Hope utilizes traditional, natural sourced treatments to discover and develop innovative pharmaceutical products. The Company is focused on parasitic diseases, particularly malaria, and AIDS and other infectious diseases, both viral and bacterial, devastating the world’s future generations. To this end Millenia has launched its first product, MMH™ Malarex/MMH™ 18, an all natural anti-malarial treatment and is developing SAR for compounds to treat AIDS, scpecifically targeting HIV-1 RNase H.
This page has been viewed 481 times since April 2007, the link to the organisation's website has been followed 65 times Recent Search Terms used to find this page: millenia hope Nov.2009 | millenia hope | millenia hope | BANKRUPT OF MILLENIA HOPE | millenia hope | millenia hope news | Malarex MMH 18 problems | Biotech Millenia Hope is bankrupt | millenia hope pharmaceuticals inc. | millenia hope pharmaceuticals website | . Search for more companies in Montreal Search for more companies in Quebec This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for Millenia Hope | |||||||||||||||||||||||||||||||||||||||||||||||||
|